Utah Medical Products
UTMD
75 hedge funds and large institutions have $220M invested in Utah Medical Products in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 12 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 28
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.17% less ownership
Funds ownership: 70.29% → 70.12% (-0.17%)
5% less capital invested
Capital invested by funds: $231M → $220M (-$11.3M)
12% less funds holding
Funds holding: 85 → 75 (-10)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$2.56M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$786K |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$676K |
| 4 |
Morgan Stanley
New York
|
+$650K |
| 5 |
Renaissance Technologies
New York
|
+$312K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$1.23M |
| 2 |
BlackRock
New York
|
-$957K |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
-$619K |
| 4 |
Two Sigma Investments
New York
|
-$539K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$415K |
UTMD Hedge Fund Activity: Q2 2022 in Review
75 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2022, worth a combined $220M — down 4.9% from $231M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of UTMD and 4 opened new positions — a net loss of 8 holders — while 28 trimmed existing stakes and 30 added.
The largest buyer was HealthInvest Partners, adding an estimated $2.56M. The largest seller was Russell Investments Group, cutting an estimated $1.23M.
- 75 institutional investors held Utah Medical Products (UTMD) as of Q2 2022, down from 85 in Q1 2022.
- Funds reported $220M of Utah Medical Products stock for Q2 2022, down 4.9% quarter-over-quarter.
- 4 funds opened new Utah Medical Products positions in Q2 2022 and 12 closed out, a net change of -8 holders.
- The largest Utah Medical Products buyer in Q2 2022 was HealthInvest Partners, an estimated $2.56M added.
- The largest Utah Medical Products seller in Q2 2022 was Russell Investments Group, an estimated $1.23M sold.
Based on aggregated 13F filings for Q2 2022.